2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Venous Thromboembolism
11
Neoplasms
9
Venous Thrombosis
8
Pulmonary Embolism
5
Pancreatic Neoplasms
5
Thrombosis
4
Thromboembolism
4
Lymphoma
3
Hemorrhage
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Ovarian Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Carcinoma, Non-Small-Cell Lung
2
Venous Thormboembolism
1
Urinary Bladder Neoplasms
1
Thrombocytopenia
1
Stroke
1
Stomach Neoplasms
1
Soft Tissue Neoplasms
1
Multiple Myeloma
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Liver Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Oxaliplatin
295
Capecitabine
209
Fluorouracil
183
Cisplatin
172
Docetaxel
140
S 1 (combination)
135
Paclitaxel
128
Leucovorin
117
Irinotecan
110
pembrolizumab
104
Trastuzumab
75
Nivolumab
59
apatinib
57
Drug Therapy
52
sintilimab
46
Surgical Procedures, Operative
45
Ramucirumab
40
Radiotherapy
40
Bevacizumab
37
Hyperthermic Intraperitoneal Chemotherapy
34
Epirubicin
32
titanium silicide
31
tislelizumab
31
Carboplatin
31
Gastrectomy
28
Cyclophosphamide
27
XELOX
25
Tegafur
24
Folfox protocol
23
Albumin-Bound Paclitaxel
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Enoxaparin
×
Clear all
NCT00718354
2015-05-13
GASTRANOX
Thrombosis Research Institute
Phase 3
Completed
740 enrolled